These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 8628011)
1. Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines. Noordhuis P; Kazemier KM; Kasperrs GJ; Peters GJ Leuk Res; 1996 Feb; 20(2):127-34. PubMed ID: 8628011 [TBL] [Abstract][Full Text] [Related]
2. Differential effect of N-(phosphonacetyl)-L-aspartate on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in human leukemia and normal bone marrow progenitors. Grant S; Rauscher F; Cadman E Cancer Res; 1982 Oct; 42(10):4007-13. PubMed ID: 6955007 [TBL] [Abstract][Full Text] [Related]
3. All-trans-retinoic acid increases cytosine arabinoside cytotoxicity in HL-60 human leukemia cells in spite of decreased cellular ara-CTP accumulation. Freund A; Rössig C; Lanvers C; Gescher A; Hohenlöchter B; Jürgens H; Boos J Ann Oncol; 1999 Mar; 10(3):335-8. PubMed ID: 10355579 [TBL] [Abstract][Full Text] [Related]
4. PALA enhancement of bromodeoxyuridine incorporation into DNA increases radiation cytotoxicity to human ovarian adenocarcinoma cells. Yang JL; Fernandes DJ; Wheeler KT; Capizzi RL Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1073-9. PubMed ID: 8600090 [TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic and DNA methylation studies of high-dose 1-beta-D-arabinofuranosyl cytosine before and after in vivo 5-azacytidine treatment in pediatric patients with refractory acute lymphocytic leukemia. Avramis VI; Mecum RA; Nyce J; Steele DA; Holcenberg JS Cancer Chemother Pharmacol; 1989; 24(4):203-10. PubMed ID: 2473850 [TBL] [Abstract][Full Text] [Related]
6. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines. Bergman AM; Munch-Petersen B; Jensen PB; Sehested M; Veerman G; Voorn DA; Smid K; Pinedo HM; Peters GJ Biochem Pharmacol; 2001 Jun; 61(11):1401-8. PubMed ID: 11331076 [TBL] [Abstract][Full Text] [Related]
7. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells. Grant S; Bhalla K; McCrady C Leuk Res; 1991; 15(4):205-13. PubMed ID: 2030601 [TBL] [Abstract][Full Text] [Related]
8. A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines. Zittoun J; Marquet J; David JC; Maniey D; Zittoun R Cancer Chemother Pharmacol; 1989; 24(4):251-5. PubMed ID: 2752506 [TBL] [Abstract][Full Text] [Related]
9. Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow. Tanaka M Leuk Res; 1993 Jul; 17(7):585-92. PubMed ID: 8326741 [TBL] [Abstract][Full Text] [Related]
10. In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine in human leukemia cells. Grant S; Boise L; Westin E; Howe C; Pettit GR; Turner A; McCrady C Biochem Pharmacol; 1991 Jul; 42(4):853-67. PubMed ID: 1867641 [TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia. Hiddemann W; Kiehl M; Zühlsdorf M; Busemann C; Schleyer E; Wörmann B; Büchner T Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573 [TBL] [Abstract][Full Text] [Related]
12. Intracellular dCTP/ara-CTP ratio and the cytotoxic effect of ara-C. Kawasaki H; Kuwabara H; Hori H; Higashigawa M; Ohkubo T; Sakurai M Cancer Invest; 1991; 9(4):409-13. PubMed ID: 1884247 [TBL] [Abstract][Full Text] [Related]
13. Unexpected synergy between N-phosphonacetyl-L-aspartate and cytidine against human tumor cells. Chan TC; Howell SB Eur J Cancer Clin Oncol; 1989 Apr; 25(4):721-7. PubMed ID: 2714348 [TBL] [Abstract][Full Text] [Related]
14. Intracellular cytosine arabinoside accumulation and cytosine arabinoside triphosphate formation in leukemic blast cells is inhibited by etoposide and teniposide. Ehninger G; Proksch B; Wanner T; Schuler U; Busch FW; Schmidt H; Schleyer E; Jaschonek K; Hiddemann W Leukemia; 1992 Jun; 6(6):582-7. PubMed ID: 1602795 [TBL] [Abstract][Full Text] [Related]
15. The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology. Wang LM; White JC; Capizzi RL Cancer Chemother Pharmacol; 1990; 25(6):418-24. PubMed ID: 2311169 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of ara-C by blast cells from patients with ANLL. Ross DD; Thompson BW; Joneckis CC; Akman SA; Schiffer CA Blood; 1986 Jul; 68(1):76-82. PubMed ID: 3719104 [TBL] [Abstract][Full Text] [Related]
17. Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells. Grant S; Rauscher F; Jakubowski A; Cadman E Cancer Res; 1981 Feb; 41(2):410-8. PubMed ID: 6160908 [TBL] [Abstract][Full Text] [Related]
18. Accumulation of arabinosyluracil 5'-triphosphate during arabinosylcytosine therapy in circulating blasts of patients with acute myelogenous leukemia. Gandhi V; Xu YZ; Estey E Clin Cancer Res; 1998 Jul; 4(7):1719-26. PubMed ID: 9676847 [TBL] [Abstract][Full Text] [Related]
19. Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937. Horber DH; Schott H; Schwendener RA Cancer Chemother Pharmacol; 1995; 36(6):483-92. PubMed ID: 7554040 [TBL] [Abstract][Full Text] [Related]
20. Formation of cytosine arabinoside-5'-triphosphate in cultured human leukemic cell lines correlates with nucleoside transport capacity. Tanaka M; Yoshida S Jpn J Cancer Res; 1987 Aug; 78(8):851-7. PubMed ID: 3115933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]